Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19907 | 484 | 29.6 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
2 | 3 | INTEGRATIVE & COMPLEMENTARY MEDICINE//CHEMISTRY, MEDICINAL//ESSENTIAL OIL | 193989 |
2241 | 2 | PAEONIFLORIN//TETRAMETHYLPYRAZINE//UNCARIA TOMENTOSA | 4728 |
19907 | 1 | TETRAMETHYLPYRAZINE//LIGUSTRAZINE//LIGUZINEDIOL | 484 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TETRAMETHYLPYRAZINE | authKW | 5272220 | 26% | 66% | 127 |
2 | LIGUSTRAZINE | authKW | 2416114 | 12% | 64% | 60 |
3 | LIGUZINEDIOL | authKW | 567797 | 2% | 100% | 9 |
4 | LIGUSTRAZINE DERIVATIVES | authKW | 386416 | 1% | 88% | 7 |
5 | LIGUSTICUM WALLICHII | authKW | 324454 | 1% | 86% | 6 |
6 | BORNEOL | authKW | 292837 | 6% | 15% | 31 |
7 | TETRAMETHYLPYRAZINE TMP | authKW | 288398 | 2% | 57% | 8 |
8 | TETRAMETHYLPYRAZINE PHOSPHATE | authKW | 252354 | 1% | 100% | 4 |
9 | CSTMP | authKW | 189266 | 1% | 100% | 3 |
10 | CXC195 | authKW | 189266 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Integrative & Complementary Medicine | 4323 | 12% | 0% | 56 |
2 | Pharmacology & Pharmacy | 2142 | 39% | 0% | 191 |
3 | Chemistry, Medicinal | 1008 | 14% | 0% | 68 |
4 | Medicine, Research & Experimental | 191 | 8% | 0% | 41 |
5 | Peripheral Vascular Diseases | 81 | 5% | 0% | 22 |
6 | Plant Sciences | 58 | 6% | 0% | 31 |
7 | Chemistry, Multidisciplinary | 55 | 10% | 0% | 48 |
8 | Hematology | 50 | 4% | 0% | 19 |
9 | Chemistry, Analytical | 27 | 5% | 0% | 23 |
10 | Neurosciences | 27 | 7% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHINESE PHARM | 79597 | 4% | 7% | 19 |
2 | BEIJING OURCE MOL DEV | 63089 | 0% | 100% | 1 |
3 | BIO ERS DRUG DEV | 63089 | 0% | 100% | 1 |
4 | BIOCHEM TISSUE ENGN UNDER STATE MINIST | 63089 | 0% | 100% | 1 |
5 | CANC CHINESE MINIST HLTH BASIC MED S | 63089 | 0% | 100% | 1 |
6 | CARDIOVASC INTEGRATED TRADIT CHINESE WES | 63089 | 0% | 100% | 1 |
7 | CHEM PROC CHINESE MAT MED | 63089 | 0% | 100% | 1 |
8 | CV GRP | 63089 | 0% | 100% | 1 |
9 | DIAG TREATMENT ENCEPHALOPATHY | 63089 | 0% | 100% | 1 |
10 | ENVIRONM CORRELAT FOOD SCI HLTH | 63089 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF CHINESE MEDICINE | 5163 | 3% | 1% | 13 |
2 | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | 2807 | 2% | 0% | 9 |
3 | ACTA PHARMACOLOGICA SINICA | 2499 | 3% | 0% | 15 |
4 | PLANTA MEDICA | 1754 | 3% | 0% | 14 |
5 | BIOLOGICAL & PHARMACEUTICAL BULLETIN | 1222 | 3% | 0% | 13 |
6 | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 918 | 2% | 0% | 9 |
7 | LETTERS IN DRUG DESIGN & DISCOVERY | 742 | 1% | 0% | 4 |
8 | CHEMISTRY CENTRAL JOURNAL | 730 | 1% | 0% | 3 |
9 | TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH | 673 | 1% | 0% | 4 |
10 | JOURNAL OF ETHNOPHARMACOLOGY | 614 | 2% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TETRAMETHYLPYRAZINE | 5272220 | 26% | 66% | 127 | Search TETRAMETHYLPYRAZINE | Search TETRAMETHYLPYRAZINE |
2 | LIGUSTRAZINE | 2416114 | 12% | 64% | 60 | Search LIGUSTRAZINE | Search LIGUSTRAZINE |
3 | LIGUZINEDIOL | 567797 | 2% | 100% | 9 | Search LIGUZINEDIOL | Search LIGUZINEDIOL |
4 | LIGUSTRAZINE DERIVATIVES | 386416 | 1% | 88% | 7 | Search LIGUSTRAZINE+DERIVATIVES | Search LIGUSTRAZINE+DERIVATIVES |
5 | LIGUSTICUM WALLICHII | 324454 | 1% | 86% | 6 | Search LIGUSTICUM+WALLICHII | Search LIGUSTICUM+WALLICHII |
6 | BORNEOL | 292837 | 6% | 15% | 31 | Search BORNEOL | Search BORNEOL |
7 | TETRAMETHYLPYRAZINE TMP | 288398 | 2% | 57% | 8 | Search TETRAMETHYLPYRAZINE+TMP | Search TETRAMETHYLPYRAZINE+TMP |
8 | TETRAMETHYLPYRAZINE PHOSPHATE | 252354 | 1% | 100% | 4 | Search TETRAMETHYLPYRAZINE+PHOSPHATE | Search TETRAMETHYLPYRAZINE+PHOSPHATE |
9 | CSTMP | 189266 | 1% | 100% | 3 | Search CSTMP | Search CSTMP |
10 | CXC195 | 189266 | 1% | 100% | 3 | Search CXC195 | Search CXC195 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHAO, YK , LIU, Y , CHEN, KJ , (2016) MECHANISMS AND CLINICAL APPLICATION OF TETRAMETHYLPYRAZINE (AN INTERESTING NATURAL COMPOUND ISOLATED FROM LIGUSTICUM WALLICHII): CURRENT STATUS AND PERSPECTIVE.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. VOL. . ISSUE . P. - | 54 | 76% | 0 |
2 | GUO, M , LIU, Y , SHI, DZ , (2016) CARDIOVASCULAR ACTIONS AND THERAPEUTIC POTENTIAL OF TETRAMETHYLPYRAZINE (ACTIVE COMPONENT ISOLATED FROM RHIZOMA CHUANXIONG): ROLES AND MECHANISMS.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 33 | 72% | 0 |
3 | GAO, HJ , LIU, PF , LI, PW , HUANG, ZY , YU, FB , LEI, T , CHEN, Y , CHENG, Y , MU, QC , HUANG, HY , (2015) LIGUSTRAZINE MONOMER AGAINST CEREBRAL ISCHEMIA/REPERFUSION INJURY.NEURAL REGENERATION RESEARCH. VOL. 10. ISSUE 5. P. 832 -840 | 34 | 51% | 5 |
4 | HAN, JZ , SUN, J , ZHU, QG , LIU, JY , HU, JH , CHEN, F , (2012) A MODIFIED LC-MS/MS METHOD FOR DETERMINATION OF TETRAMETHYLPYRAZINE IN MICRODIALYSIS SAMPLES AND CALIBRATION OF HOME-MADE LINEAR PROBES.BIOMEDICAL CHROMATOGRAPHY. VOL. 26. ISSUE 10. P. 1276 -1281 | 16 | 89% | 6 |
5 | XU, K , WANG, PL , XU, X , CHU, FH , LIN, JX , ZHANG, YZ , LEI, HM , (2015) AN OVERVIEW ON STRUCTURAL MODIFICATIONS OF LIGUSTRAZINE AND BIOLOGICAL EVALUATION OF ITS SYNTHETIC DERIVATIVES.RESEARCH ON CHEMICAL INTERMEDIATES. VOL. 41. ISSUE 3. P. 1385 -1411 | 17 | 77% | 2 |
6 | TAN, F , FU, WJ , CHENG, NF , MENG, D , GU, Y , (2015) LIGUSTRAZINE REDUCES BLOOD-BRAIN BARRIER PERMEABILITY IN A RAT MODEL OF FOCAL CEREBRAL ISCHEMIA AND REPERFUSION.EXPERIMENTAL AND THERAPEUTIC MEDICINE. VOL. 9. ISSUE 5. P. 1757 -1762 | 14 | 61% | 3 |
7 | XIAO, YY , PING, QN , CHEN, ZP , (2007) THE ENHANCING EFFECT OF SYNTHETICAL BORNEOL ON THE ABSORPTION OF TETRAMETHYLPYRAZINE PHOSPHATE IN MOUSE.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 337. ISSUE 1-2. P. 74-79 | 9 | 100% | 29 |
8 | WANG, YT , TU, QF , YAN, W , XIAO, D , ZENG, ZM , OUYANG, YM , HUANG, L , CAI, J , ZENG, XL , CHEN, YJ , ET AL (2015) CXC195 SUPPRESSES PROLIFERATION AND INFLAMMATORY RESPONSE IN LPS-INDUCED HUMAN HEPATOCELLULAR CARCINOMA CELLS VIA REGULATING TLR4-MYD88-TAK1-MEDIATED NF-KAPPA B AND MAPK PATHWAY.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 456. ISSUE 1. P. 373 -379 | 12 | 52% | 13 |
9 | TOTH, S , PEKAROVA, T , VARGA, J , TOTH, S , TOMECKOVA, V , GAL, P , VESELA, J , GUZY, J , (2013) INTRAVENOUS ADMINISTRATION OF TETRAMETHYLPYRAZINE REDUCES INTESTINAL ISCHEMIA-REPERFUSION INJURY IN RATS.AMERICAN JOURNAL OF CHINESE MEDICINE. VOL. 41. ISSUE 4. P. 817-829 | 14 | 54% | 4 |
10 | YAMADA, K , SANO, N , FUJIHARA, H , OHTA, A , (2003) EFFECT OF 2,5-DIMETHYLPYRAZINE ON UTERINE CONTRACTION IN LATE STAGE OF PREGNANT FEMALE RATS.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 26. ISSUE 11. P. 1614 -1617 | 11 | 85% | 0 |
Classes with closest relation at Level 1 |